Skip to content
healthcare.dev
Get a free key

Diatrizoate Meglumine and Diatrizoate Sodium

NDC 31722-019, Diatrizoate Meglumine and Diatrizoate Sodium, solution, from Camber Pharmaceuticals, Inc..

Product NDC
31722-019
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
SOLUTION
Route
ORAL, RECTAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215049
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIATRIZOATE MEGLUMINE660 mg/mL
  • DIATRIZOATE SODIUM100 mg/mL

Pharmacologic classes

Radiographic Contrast Agent [EPC]; Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]; X-Ray Contrast Activity [MoA]

Package NDCNDC-11Package
31722-019-313172200193124 BOTTLE in 1 BOX (31722-019-31) / 30 mL in 1 BOTTLE (31722-019-30)
31722-019-323172200193212 BOTTLE in 1 BOX (31722-019-32) / 120 mL in 1 BOTTLE (31722-019-12)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a216a7d5-3c28-482b-956a-93ae146e3763

Use it

Look up 31722-019 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-019 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-019. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.